(Q41597843)

4 October 2017

Substance P increases in vitro lymphokine-activated-killer (LAK) cell cytotoxicity against fresh colorectal cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279274

8 September 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

20 November 2023

author name string

H. Flageole

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279274

8 September 2022

M. Senterman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279274

8 September 2022

J. L. Trudel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279274

8 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1279274

8 September 2022

publication date

1 November 1992

1 reference

full work available at URL

4 October 2017

http://escholarship.mcgill.ca/downloads/w37638188

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1279274

https://api.elsevier.com/content/article/PII:002248049290088H?httpAccept=text/xml

20 November 2023

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

https://api.elsevier.com/content/article/PII:002248049290088H?httpAccept=text/plain

20 November 2023

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Journal of Surgical Research

20 November 2023

published in

1 reference

4 October 2017

53

1 reference

4 October 2017

5

1 reference

4 October 2017

445-449

1 reference

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

4 October 2017

6

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

20 November 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Lymphokine-activated killer (LAK) cells from human intestinal mucosa: Cytotoxic activity against tumor cell lines and modified self but not autologous and allogeneic colon cancer cells

20 November 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate

20 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Influence of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride

20 November 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Substance P recognition by a subset of human T lymphocytes

20 November 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Isolation and functional characterization of human intestinal mucosal lymphoid cells

20 November 2023

16

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Partial purification of human colonic carcinoma cells by sedimentation

20 November 2023

17

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses

20 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Chemical design of antagonists of substance P

20 November 2023

20

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Neuropeptide-immunoreactive cells in human thymus.

20 November 2023

21

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A

20 November 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Substance P increases and prolongs increased output of T4 (CD4) lymphocytes from lymph nodes of sheep in vivo: is it a mediator of immunological memory?

20 November 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Substance P increases lymphocyte traffic and lymph flow through peripheral lymph nodes of sheep

20 November 2023

24

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Antipeptide antibodies that recognize a lymphocyte substance P receptor

20 November 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

Substance P: a modulator of neuroendocrine-immune function

20 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/0022-4804(92)90088-H

20 November 2023

Identifiers

1 reference

4 October 2017

1 reference